Osama Alhamarneh
Serum IL10 and circulating CD4+CD25high regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma
Alhamarneh, Osama; Agada, Frank; Madden, Leigh; Stafford, Nicholas; Greenman, John
Authors
Frank Agada
Dr Leigh Madden L.A.Madden@hull.ac.uk
Post-Doctoral Research Assistant
Nicholas Stafford
Professor John Greenman J.Greenman@hull.ac.uk
Professor of Tumour Immunology
Abstract
Background. Patients with head and neck squamous cell carcinoma (HNSCC) commonly have an imbalance in T helper (Th)1/Th2-type cytokines and elevated levels of CD4 + CD25 high regulatory T cells (Treg). Here, we investigated the association of circulating interleukin (IL)10, IL12, and Treg-cells with clinical outcome in patients with HNSCC. Methods. Serum cytokine levels were determined by enzyme-linked immunosorbent assay (ELISA) in patients' pretreatment (n = 107) and 4 to 6 weeks posttreatment (n = 43), and in nontumor controls (n = 40). Treg-cell levels were determined by flow cytometry. Results. IL10 detectability was significantly higher in patients than controls (p =.001). Pretreatment IL10 levels in all anatomical subsites, except the oral cavity, were significantly elevated in stages III/IV, N+ patients, and in T3/4-tumors (p =.005,.037, and.001, respectively). The detectability of IL10 significantly correlated with poorer survival after a maximum follow-up of 36 months. Treg-cell levels did not correlate with any clinical parameters. Conclusion. IL10 is a potential independent factor in predicting a poor clinical outcome in newly presenting tumors of laryngeal and pharyngeal origin. The role of circulating Treg-cells as predictors of clinical outcome requires further investigation. Copyright © 2009 Wiley Periodicals, Inc.
Citation
Alhamarneh, O., Agada, F., Madden, L., Stafford, N., & Greenman, J. (2011). Serum IL10 and circulating CD4+CD25high regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Head & neck, 33(3), 415-423. https://doi.org/10.1002/hed.21464
| Journal Article Type | Article |
|---|---|
| Acceptance Date | Mar 30, 2010 |
| Online Publication Date | Jul 19, 2010 |
| Publication Date | Mar 1, 2011 |
| Journal | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK |
| Print ISSN | 1043-3074 |
| Publisher | Wiley |
| Peer Reviewed | Peer Reviewed |
| Volume | 33 |
| Issue | 3 |
| Pages | 415-423 |
| DOI | https://doi.org/10.1002/hed.21464 |
| Keywords | Otorhinolaryngology |
| Public URL | https://hull-repository.worktribe.com/output/400122 |
You might also like
Abstract A020: Calcitonin receptor-like receptor is expressed in blood vessels in clear cell renal cell carcinoma and upregulated in endothelial cells co-cultured with tumor cells
(2023)
Presentation / Conference Contribution
Abstract B001: Calcitonin receptor-like receptor agonists induce p44/42 MAPK phosphorylation in VEGF-A-stimulated human blood endothelial cells after bevacizumab treatment
(2023)
Presentation / Conference Contribution
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search